GetTenderAI

France – Services de recherche et développement expérimental – Caractérisation fonctionnelle d’anticorps à visée thérapeutique

DeadlineAugust 25, 2026 at 11:00 AM34 days left

AI summary

This tender concerns research and development services for functional characterization of therapeutic antibodies in cancer pathology. The project aims to evaluate antibodies for antigen/tumor cell recognition specificity and tumor cell depletion capacity using in vitro cell models and in vivo murine models.

#antibody characterization#cancer immunotherapy#research development#in vitro testing#murine models#paris#france
Fit for

Research institutions, contract research organizations (CROs), or biotech companies with proven experience in immunology and therapeutic antibody development should apply.

Key requirements

Suppliers must possess expertise in antibody characterization, tumor immunology, and both in vitro and in vivo experimental methodologies. Laboratory facilities capable of conducting cellular assays and murine studies are essential.

Frequently asked questions

  • What is this tender about?

    This tender concerns research and development services for functional characterization of therapeutic antibodies in cancer pathology. The project aims to evaluate antibodies for antigen/tumor cell recognition specificity and tumor cell depletion capacity using in vitro cell models and in vivo murine models.

  • What are the requirements for suppliers?

    Suppliers must possess expertise in antibody characterization, tumor immunology, and both in vitro and in vivo experimental methodologies. Laboratory facilities capable of conducting cellular assays and murine studies are essential.

  • What type of company should bid?

    Research institutions, contract research organizations (CROs), or biotech companies with proven experience in immunology and therapeutic antibody development should apply.

  • Who is the buyer?

    The buyer is Université Paris Cité.

  • When does this tender close?

    Submissions close on August 25, 2026.

Le présent marché a pour objet la caractérisation fonctionnelle d’anticorps à visée thérapeutique dans le cadre de pathologies cancéreuses. L’objectif est de caractériser les anticorps d'intérêt en termes de spécificité de reconnaissance d'un antigène/d’une cellule tumoral(e) et de capacité à promouvoir la déplétion de cellules tumorales, à la fois in vitro, dans des modèles cellulaires, et in vivo, dans des modèles murins.

Buyer
Université Paris Cité
Buyer ID: 13002573700011
85 boulevard Saint-Germain, 75006, PARIS
01 76 53 18 66achats.dfa@u-paris.frhttps://u-paris.fr
Body responsible for review procedures
Tribunal administratif de Paris
Buyer ID: 17750005500013
7 rue de Jouy, F-75181 Paris Cedex 04, PARIS
01 44 59 44 00greffe.ta.paris@juradm.frhttps://paris.tribunal-administratif.fr

Computing match…

AI document analysis

We read the tender PDFs and DOCX files and surface key requirements, deadlines, budget and red flags.

Loading…